Canadian

Canadian
Pari-Mutuel
canadienne
du pari mutuel
Elimination Guidelines Her Majesty the Queen in Right of Canada, as represented by the Minister of Agriculture and Agri-food Canada, 2016 Catalogue: A22-147/2016 ISBN: 978-0-660-03756-1 CONTENTS
INT RODUCT ION………………………………………………….4 DRUG ADMINIST RAT ION DAT A………………………………9 The information on drug excretion rates does not constitute and is not a warranty, guarantee, assurance, undertaking or anything similar that the results of the use of any of the drugs in the manner set out wil be as stated. Agriculture and Agri-Food Canada is not responsible for results differing in any way from the results stated herein. Use of information in this booklet does not relieve or lessen any trainer's responsibility for assuring that, during a horse race, a horse is free from any drug listed in the Schedule to the Pari-Mutuel Beting Supervision Regulations and for complying with provisions of the Regulations and provincial racing rules. Owners, trainers or any other person in charge or having care of a race horse are strongly advised to consult their own veterinarian for advice and guidance in the use of all drugs. The guidelines in this booklet are SPEC IFIC to the stated
products, dosages and routes of administration and may not be
consistent with foreign re gulations and laboratory me thods.
T he use of other products such as compounded medications with
the same active ingredient(s) may result in drug eliminations
which are not consistent with these guidelines.
IMPORTANT
Each pharmaceutical product approved for sale in Canada is assigned a "Drug Identification Number" (D.I.N.), which is marked on the product label. Veterinary drugs are marked "(For) Veterinary Use Only" or "(For) Agricultural Use Only" on the product label. EXAMINE ALL PRO DUCT LABELS CAREFULLY!
CPMA Elim ination Guidelines GENERAL NOTES
1. This booklet is provided for the information of veterinarians and horse people. T his edition replaces all previous editions. 2. Amendments to the Pari-Mutuel Betting Supervision Regulations and the Schedule may be made at any time. 3. Detection and confirmation of any of the scheduled drugs, in an official sample, shall constitute a positive test in accordance with Pari-Mutuel Betting Supervision Regulations. 4. The Elimination Booklet is in effect as of March 1, 2016.

(English)
(French)
1-800-268-8835
CPMA Elimination Guidelines CPMA addresses:

HEADQ UARTERS
REFER ENC E & RESEARC H
Exe cutive Dire ctor
LABO RATO RY
Canadian Pari-Mutuel Agency Canadian Pari-Mutuel Agency 960 Carling Ave, bldg. 74 1130 Morrison Drive Ottawa, ON K1A 0C6 Suite 101 Ottawa, ON K2H 9N6 T el: 613-759-6100 T el: 613-949-0745 Fax: 613-759-6230 Fax: 613-949-1538 MAILING:
Ottawa, ON K2C 3X7 [email protected]
EQ UINE DRUG
EVALUATIO N C ENTRE
Canadian Pari-Mutuel Agency
Agriculture & Agri Food
115 Sunnyridge Road
R.R. 1
Jerseyville, ON L0R 1R0
T el: 905-648-3033
Fax: 905-648-8425
CPMA Elim ination Guidelines Agriculture and Agri-Food Canada, through the Equine Drug Control Program of the Canadian Pari-Mutuel Agency (CPMA), conducts research into equine drug administration, a program designed to aid the racing industry. The research involves standardbred mares stabled at the Agriculture and Agri-Food Canada Equine Drug Evaluation Centre. Analysis is conducted by the CPMA and Official Racing Laboratories in
Canada using methods employed for routine samples.
The Elimination Guidelines indicating the approximate length
of time that some drugs can be detected in the blood and urine
of horses, are one outcome of this research. The approximate
nature of the data presented is stressed. Drug absorption and
elimination are influenced by many factors, including the
horse (age, sex, etc.), its environment (diet, training, etc.) and
the drug (dosage, drug mixture, etc.). You should be aware
that the dosage of the drug may vary with different
preparations and manufacturers. Be sure to read the label of
the product before use. T aking all factors into consideration,
individual horses may have longer or shorter periods of
elimination. You should consult with your veterinarian for advice and guidance in the administration of drugs to your horse. The Elimination Guidelines are intended as information only and do not, in any way, supersede or relieve responsibility for compliance with the Pari-Mutuel Betting Supervision Regulations and provincial racing rules. If you are not already, you should become familiar with these rules. Agriculture and Agri-Food Canada and the Official Racing Laboratories assume no liability for positive tests which may occur as the result of drugs administered within quantity and time frames set out in this publication. T he following page describes typical information found on each of the pages describing a particular drug. CPMA Elimination Guidelines Generic (or Common) Drug Name e.g. LIDOCAINE
Trade and Other Names e.g. Octocaine, Lignocaine, Xylocaine, Duracaine, Lido Type of Drug e.g. Local Anesthetic (for definitions, see Glossary) Route of Administration e.g. Aeromask Inhaler (AER) Intravenous Injection (IV) Infiltration (INFIL) Nebulization (NEB) Intra-articular Injection (IA) Intramuscular Injection (IM) Subcutaneous Injection (SC) Intra-synovial Injection (ISY) Intratracheal (IT ) Dosage Regimen and Elimination Guideline (EG) Trade name Dose e.g. 500 mg (milligrams) (Standardbr ed of product 1 g (1 gram = 1000 mg) mares) administered Elimination Guideline (Sample time, after final dose, after which no drug or metabolite was detected using current methodology) Example: Elimination guideline = 120+ hrs: At
this dosage, most horses would test positive for
longer than 120 hrs after the last treatment.
It is stressed that these Elimination Guidelines are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines GLOSSARY – TYPE OF DRUG
Androgenic Anabolic A drug that possesses anabolic (musculature, Steroid: size) and androgenic activity (masculinization, behavioural effects). A drug that relieves pain. An antiparasitic or worming agent. A drug that destroys or prevents the growth of bacteria. Anticholinergic: A drug that antagonizes bronchospasm, (anti-muscarinic) reduces respiratory secretions and gastro-intestinal hypermotility. Anti-congestive: A drug that relieves nasal congestion. A drug that prevents or relieves involuntary contraction of muscles. A drug that relieves depression and has the ability to alter behaviour. Antifibrinolytic: A drug that inhibits the breakdown of fibrin which is important in the blood clotting mechanism. A drug that relieves the symptoms of alergy. Many antihistaminic drugs have sedative side effects. Antihypertensive: A drug that acts against abnormally high blood pressure and emotional tension. Anti-inflammatory: A drug that relieves local swelling, redness and pain caused by an injury or infection. A drug that reduces a fever. CPMA Elimination Guidelines GLOSSARY – TYPE OF DRUG (cont.)
A drug that expands the diameter of the bronchial tubes, permitting easier breathing. Counterirritant: An agent producing mild surface irritation of skin with the object of relieving deep-seated inflammation. A drug causing increased production and excretion of urine. A drug that promotes the clearing of phlegm from chest or lungs. Gastric Acid Secretion A drug that inhibits gastric acid secretion Inhibitor: and aids in ulcer therapy. General Anesthetic: A drug producing a lack of sensation and a level of sedation required for major A drug that aids in the prevention Histamine H2 Receptor A drug that inhibits gastric acid Antagonist: secretion, aids in peptic ulcer therapy. An agent producing sloughing of the surface layers of skin. Local Anesthetic: A drug producing reduced sensations (e.g. touch, pain) in a restricted area of the body. A drug that breaks down or liquefies Non-steroidal anti-inflammatory drug. CPMA Elim ination Guidelines GLOSSARY – TYPE OF DRUG (cont.)
A drug that acts to produce rhythmic contractions of the uterus. Penetrant Carrier: A substance that enhances the absorption of other drugs. A drug that aids in control of allergic respiratory disease and cough, and reduces pulmonary hyperactivity. A drug that produces a calming effect and reduces nervous excitement. A drug that relaxes the muscles involved Sympathomimetic: A drug that mimics the actions of the sympathetic nervous system. A drug producing an action similar to that of a steroid hormone of the adrenal cortex, but which is chemically distinguishable from natural hormones. A drug that relieves anxiety and other stress-related symptoms. A drug that causes dilation of blood CPMA Elimination Guidelines Trade and Other Names Acetylpromazine, Acetazine, Atravet, Anatran, Aceprozine, Tranozine, Tranquavet Type of Drug Route of Administration IM, IV, Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration EG Atravet 10 mg PO Atravet 10 mg PO Atravet 50 mg PO Atravet 10 mg IM Atravet 25 mg IM It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
ACETAMINOPHEN
Trade and Other Names Paracetamol, Atasol, Tylenol, Exdol, Dolophen, Paraphen, Type of Drug Analgesic; Antipyretic Route of Administration Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods. CPMA Elimination Guidelines AMINOCAPROIC ACID
Trade and Other Names Amicar Type of Drug Antifibrinolytic Route of Administration IV Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines ATROPINE
Trade and Other Names Atropine Sulfate Type of Drug Anticholinergic Route of Administration IV Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines Trade and Other Names Qvar Type of Drug Anti-inflammatory; Synthetic Corticosteroid Route of Administration Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names Celestone Soluspan Type of Drug Anti-inflammatory; Synthetic Corticosteroid Route of Administration IA Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration EG Soluspan 18 mg IA It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered.
The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines BUPIVACAINE
Trade and Other Names Marcaine Type of Drug Local anesthetic Route of Administration IM Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG Marcaine 50 mg IM It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines BUTORPHANOL
Trade and Other Names Torbugesic Type of Drug Analgesic; Antitussive Route of Administration IV Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered.
The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names Buscopan Type of Drug Anticholinergic Route of Administration IV, Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration Buscopan 140 mg PO It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
CARBAZOCHROME
Trade and Other Names Kentucky Red Type of Drug Hemostatic Route of Administration IV Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines CARPROFEN
Trade and Other Names Rimadyl Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Product Dose/Route Administration
Note: At this dosage, most horses would test positive for longer
than 120 hours after the last treatment.

It is stressed that these results are presented as guidelines only and
should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
CHLOROPROCAINE
Trade and Other Names Nesacaine Type of Drug Local Anesthetic Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines CHLORPHENIRAMINE
Trade and Other Names Chlortripolon, Histalon, Novopheniram, Chlorophen, Inactihist Type of Drug Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names Largactil, Chlorpromanyl, Chlorprom, G Promazine, Apo Chlorpromazine, Novochlorpromazine Type of Drug Route of Administration Dosage Regimen and Elimination Guideline (EG) Product Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered.
The guidelines in this booklet may not apply to a compounded product
and may not be consistent with foreign regulations and laboratory
methods.
CPMA Elim ination Guidelines CIMETIDINE
Trade and Other Names Tagamet, Peptol Type of Drug Histamine H2 Receptor Antagonist Route of Administration Dosage Regimen and Elimination Guideline (EG) Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines CLENBUTEROL
Trade and Other Names Ventipulmin Type of Drug Bronchodilator Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names Clomicalm Type of Drug Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG
Note: At this dosage, most horses would test positive for longer
than 120 hours after the last treatment.
It is stressed that these results are presented as guidelines only and
should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names Cromovet, Cromolyn, Intal Type of Drug Respiratory anti-allergic Route of Administration NEB, AER Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines CYPROHEPTADINE
Trade and Other Names Periactin Type of Drug Antihistamine Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods. CPMA Elim ination Guidelines DANTROLENE
Trade and Other Names Dantrium Type of Drug Skeletal Muscle Relaxant Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG
It is stressed that these results are presented as guidelines only and
should not be construed as absolute for every horse to which this
drug is administered.

The guidelines in this booklet may not apply to a compounded product
and may not be consistent with foreign regulations and laboratory
methods.
CPMA Elim ination Guidelines DEMBREXINE
Trade and Other Names Sputolysin Type of Drug Mucolytic; Expectorant Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG Sputolysin 150 mg PO Sputolysin 150 mg PO It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods. CPMA Elim ination Guidelines DETOMIDINE
Trade and Other Names Dormosedan Type of Drug Analgesic, sedative Route of Administration IV, SL Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration Dormosedan 20 mg IV It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered.
The guidelines in this booklet may not apply to a compounded product
and may not be consistent with foreign regulations and laboratory
methods.
CPMA Elim ination Guidelines DEXAMETHASONE
Trade and Other Names Dexamethasone 5, Dexamethasone Powder Type of Drug Anti-inflammatory; Synthetic Corticosteroid Route of Administration IV, Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG once daily, 48 h It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names Democineol, Sedatuss, Broncho Grippol, Tussorphan, Robidex, Type of Drug Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG Dextromethorphan It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines DIAZEPAM
Trade and Other Names Type of Drug Tranquilizer Route of Administration IM, Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration Note: At this dosage, most horses would test positive for
longer than 120 hours after the last treatment.

It is stressed that these results are presented as guidelines only and
should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines DICLOFENAC
Trade and Other Names Voltaren; Diclofenac Sodium Gel Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO), TOP (as leg rub) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory CPMA Elimination Guidelines DIFLUNISAL
Trade and Other Names Dolobid Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names DMSO, Domoso, Rimso, Kemsol Type of Drug Analgesic/Anti-inflammatory (NSAID); Penetrant Carrier Route of Administration TOP (as leg rub), IV Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines DIPHENHYDRAMINE
Trade and Other Names Benadryl, Sominex, Compoz, Nytol Type of Drug Antihistamine Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration Benadryl 250 mg IM Benadryl 500 mg PO It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines DIPYRONE
Trade and Other Names Methampyrone, Novolate, Diprone, Novin, Myovin, Dipyrone 50%, Metamizol Type of Drug Analgesic, Antipyretic Route of Administration Dosage Regimen and Elimination Guideline (EG) Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines DYPHYLLINE
Trade and Other Names Type of Drug Bronchodilator Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
ENALAPRIL
Trade and Other Names Enacard Type of Drug Antihypertensive Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines EPHEDRINE
Trade and Other Names Antiphrine, Anti-Histamine (also contains Pyrilamine) Type of Drug Sympathomimetic, anti-congestive Route of Administration IM, Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG Antiphrine 200 mg PO Histamine 200 mg IM Histamine 300 mg PO It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
ERGONOVINE
Trade and Other Names Ergonovine Maleate Type of Drug Oxytocic Route of Administration IV Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines ETHACRYNIC ACID
Trade and Other Names Type of Drug Diuretic Route of Administration IV, Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
ETODOLAC
Trade and Other Names Ultradol Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines FAMOTIDINE
Trade and OtherNames Pepcid, Ulcidine Type of Drug Histamine H2 Receptor Antagonist Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines FENOTEROL
Trade and Other Names Berotec Type of Drug Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines FIROCOXIB
Trade and Other Names Previcox Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration


It is stressed that these results are presented as guidelines only and
should not be construed as absolute for every horse to which this
drug is administered.
The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names Idarac Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines FLUNIXIN
Trade and Other Names Banamine Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration IV, IM, Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration Banamine 500 mg PO Banamine 500 mg IV Banamine 500 mg IM Banamine 500 mg IM Banamine 500 mg IM It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names Type of Drug Tranquilizer/Sedative Route of Administration IM Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG Modecate 50 mg IM It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines FLURBIPROFEN
Trade and Other Names Ansaid Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines FUROSEMIDE
Trade and Other Names Lasix, Salix, Lasix Special Type of Drug Diuretic; Antihypertensive Route of Administration IV, IM, Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines GLYCOPYRROLATE
Trade and Other Names Robinul Type of Drug Anticholinergic Route of Administration IV, IM Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines GUAIFENES IN
Trade and Other Names Glyceryl Guaiacolate, Guaiacol Glyceryl Ether Gecolate, Type of Drug Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines HYDROCHLOROTHIAZIDE
Trade and Other Names Vetazide, Hydro Aquil, Hydrodiuril Urozide, Edemol Type of Drug Diuretic; Antihypertensive Route of Administration Dosage Regimen and Elimination Guideline (EG) Product Dose/Route Administration Vetazide 100 mg IV It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines HYDROXYZINE
Trade and Other Names Hydroxyzine Type of Drug Antihistamine Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines IBUPROFEN
Trade and Other Names Motrin Type of Drug Analgesic, Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
INDAPAMIDE
Trade and Other Names Type of Drug Diuretic, Antihypertensive Route of Administration Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names Indocid, Infrocin, Novomethacin Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
ISOFLUPREDONE
Trade and Other Names Predef 2X, 9-Fluoroprednisolone Type of Drug Anti-inflammatory; Synthetic Corticosteroid Route of Administration IM Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines KETAMINE
Trade and Other Names Ketaset, Ketalar, Vetalar Type of Drug General Anesthetic Route of Administration IV Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines KETOPROFEN
Trade and Other Names Ketofen, Anafen Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration IV Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines KETOTIFEN
Trade and Other Names Zaditen Type of Drug Respiratory anti-allergic Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines LIDOCAINE
Trade and Other Names Lignocaine, Xylocaine, Duracaine, Lido, Octocaine, Lignospan Type of Drug Local Anesthetic Route of Administration Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG *Topical product also contains 18 g DMSO It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines MECLOFENAMIC ACID
Trade and Other Names Arquel Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines MEFENAMIC ACID
Trade and Other Names Ponstan Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines MELOXICAM
Trade and Other Names Metacam Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration IV, Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines MEPIVACAINE
Trade and Other Names Carbocaine Type of Drug Local Anesthetic Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG Carbocaine 300 mg IA Carbocaine 300 mg SC It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names Robaxin Type of Drug Skeletal Muscle Relaxant Route of Administration IV, Oral (PO) Dosage Regimen and Elimination Guideline (EG) Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods. CPMA Elim ination Guidelines Trade and Other Names Depo Medrol Type of Drug Anti-inflammatory; Synthetic Corticosteroid Route of Administration IA Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines NABUMETONE
Trade and Other Names Relafen Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines NAPROXEN
Trade and Other Names Naprosyn, Equiproxen Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines NEDOCROMIL
Trade and Other Names Tilade, Alocril Type of Drug Bronchial anti-inflammatory, Respiratory anti-allergic Route of Administration AER Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines OXAPROZIN
Trade and Other Names Daypro Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration
At this dosage, most horses would test positive for longer than
120 hours after the last treatment.

It is stressed that these results are presented as guidelines only and
should not be construed as absolute for every horse to which this drug
is administered.
The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines PENTAZOCINE
Trade and Other Names Talwin Type of Drug Analgesic Route of Administration IM Dosage Regimen and Elimination Guideline (EG) #Horses Product Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
PENTOXIFYLLINE
Trade and Other Names Trental, Navicon Type of Drug Vasodilator Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names Phenothiazine Type of Drug Anthelmintic Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG Drench Grade 4.75 g PO It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. T he guidelines in the booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods. CPMA Elim ination Guidelines
PHENYLBUTAZONE
Trade and Other Names Bute, Butazolidin, Dinz, Butazone, Equipalazone, Azrabute, Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG once daily, 3 96 h It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines PHENYTOIN
Trade and Other Names Dilantin, Phenytoin Suspension Type of Drug Anticonvulsant, Antiarhythmic Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
PIROXICAM
Trade and Other Names Feldene Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines Trade and Other Names Solu Delta Cortef (prednisolone sodium succinate), Prednisolone Acetate Type of Drug Anti-inflammatory; Synthetic Corticosteroid Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration twice daily, 48 h It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines PREDNISONE
Trade and Other Names Deltasone Type of Drug Anti-inflammatory; Synthetic Corticosteroid Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines PROCAINE HYDROCHLORIDE
Trade and Other Names Novocain Type of Drug Local Anesthetic Route of Administration INFIL Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration Novocain 1600 mg INFIL It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
PENICILLIN G PROCAINE
Trade and Other Names Derapen A, Azimycin, Cillimycin, Penamycin, Pen-Strep Suspension, Pen Di Strep, Procillin, Ethacillin, Diathol, Pro-Pen Feedmix, Special Formula 17900 Type of Drug Antibiotic (contains local anesthetic component: Procaine) Route of Administration IM, Oral (PO), TOP Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG *IU= International Units (1 milion IU Penicil in G Procaine contains 424 mg Procaine) . continued overleaf CPMA Elimination Guidelines PENICILLIN G PROCAINE (cont'd)
Dose/Route Administration **Also contains 200 mg procaine hydrochloride It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
PYRILAMINE
Trade and Other Names Histosol, Anti-Histamine (also contains Ephedrine) Type of Drug Antihistamine Route of Administration IM, Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines RANITIDINE

Trade and Other Names
Type of Drug Histamine H2 Receptor Antagonist Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
RESERPINE
Trade and Other Names Reserpine Type of Drug Tranquilizer Route of Administration IM Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG Reserpine 2.5 mg IM It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines ROMIFIDINE
Trade and Other Names Sedivet Type of Drug Sedative Route of Administration IV Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
SALBUTAMOL
Trade and Other Names Ventolin Type of Drug Bronchodilator Route of Administration AER Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines SALMETEROL
Trade and Other Names Serevent Type of Drug Bronchodilator Route of Administration AER Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines
SULINDAC
Trade and Other Names Clinoril Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines TENOXICAM
Trade and Other Names Mobiflex Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines TERBUTALINE
Trade and Other Names Bricanyl, Brethine Type of Drug Route of Administration Oral (PO), SC Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines Trade and Other Names Aminophylline: Somophyllin, Aminophyl, Corophyllin, Theophylline: Acet-Am, Quibron, Asthmophylline, Theolair Type of Drug Bronchodilator Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolut e for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines TIAPROFENIC ACID
Trade and Other Names Surgam Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines TRIAMCINOLONE ACETONIDE
Trade and Other Names Kenalog-10 Type of Drug Anti-inflammatory; Synthetic Corticosteroid Route of Administration IA Dosage Regimen and Elimination Guideline (EG) #Horses Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines Trade and Other Names Naquasone Type of Drug Diuretic; Antihypertensive Route of Administration Oral (PO), IV, IM Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG Naquasone 100 mg PO Naquasone 200 mg PO Naquasone 100 mg IV Naquasone 100 mg IM It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines TRIPELENNAMINE
Trade and Other Names Type of Drug Antihistamine Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines VEDAPROFEN
Trade and Other Names Quadrisol Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG once daily on 48 h It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines XYLAZINE
Trade and Other Names Type of Drug Skeletal Muscle Relaxant; Analgesic; Sedative Route of Administration IV Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elim ination Guidelines ZOMEPIRAC
Trade and Other Names Zomax Type of Drug Analgesic/Anti-inflammatory (NSAID) Route of Administration Oral (PO) Dosage Regimen and Elimination Guideline (EG) Dose/Route Administration EG It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. The guidelines in this booklet may not apply to a compounded product and may not be consistent with foreign regulations and laboratory methods.
CPMA Elimination Guidelines T --------------
CPMA Elim ination Guidelines SCHEDULE
List of Drugs
1. Any substance and any preparation, metabolite, derivative,
isomer and salt of the substance, (a) that is label ed for veterinary use under the Food and Drug Regulations during a period of 240 days, calculated from the day on which the drug was assigned a drug identification number (D.I.N.) under those Regulations; (b) that is not labelled for veterinary use under the Food and Drug Regulations; (c) that interferes with an analysis for any drug included in this schedule; or (d) that is included in the followin g list: (Acépromazine) (Buprénorphine) Acetanilide (Acétanilide) Caffeine (Caféine) Acetylsalicylic acid (Acide Camphor (Cam phre) Carbachol (Carbachol) Aconite (Aconit) Carfentanil (Carfentanil) Aconitine (Aconitine) Carprofen (Carprofène) Alphadolone (Alphadolone) Chloral Hydrate (Hydrate Alphaxalone (Alphaxalone) de chloral) Chlorpheniramine (Am inophylline) (Chlorphéniram ine) Antipyrine (Antipyrine) Clenbuterol (Clenbutérol) Arecoline (Arécoline) Atipamezole (Atipamézole) (Clom ipram ine) Atropine (Atropine) Azaperone (Azapérone) (Crom oglycate) Belladonna (Belladone) Dembrexine (Dembrexine) Benazepril (Benazépril) Deracoxib (Déracoxib) Benzocaine (Benzocaïne) Desoxycorticosteron e (Bétam éthasone) Detomidine (Détom idine) Boldenone (Boldénone) Butacaine (Butacaïne) (Dexam éthasone) Butorphanol (Butorphanol) Dibucaine (Dibucaïne) CPMA Elimination Guidelines Diethylstilbe strol (Lévam isole) Lidocaine (Lidocaïne) Digitalis (Digitaline) Lobelia (Lobelia) Digitoxin (Digitoxine) Lobeline (Lobéline) Digoxin (Digoxin) Mebezonium (Mébézonium) Dimethylsulfo xide Meclofenamic acid (Acide (Dim éthylsulfoxyde) m éclofénam ique) Diphemanil (Diphémanil) (Médetom idine) (Diprénorphine) Meloxicam (Méloxicam ) Dipyrone (Dipyrone) Mepivacaine (Mépivacaïne) Doxapram (Doxapram ) Droperidol (Dropéridol) Enalapril (Énalapril) Methotrimeprazine Ephedrine (Éphédrine) (Méthotrim éprazine) Epinephrine (Épinéphrine) Methscopolamin e Ergonovine (Ergonovine) (Methscopolam ine) Ethanol (Ethanol) Methylpredniso lon e Etorphine (Étorphine) Fentanyl (Fentanyl) Methyl Salicylate Firocoxib (Firocoxib) (Salicylate de m éthyle) Methyltestosterone (Flum éthasone) Flunixin (Flunixine) Metomidate (Métom idate) Fluocinolone acetonide (Acétonide de fluocinolone) (Mom étasone) Fluoxetine (Fluoxetine) Naloxone (Naloxone) Fomepizole (Fom épizole) Nandrolone (Nandrolone) Furosemide (Furosém ide) Neostigmine (Néostigm ine) Guaifenesin (Guaifénésine) Nicotine (Nicotine) Hydrochlorothiaz ide Nikethamide (Nikétham ide) Nux Vomica (Nux Vomica) Hyoscine (Hyoscine) Penicillin G Procaine (Pénicilline G Procaïne) (Hyoscyam ine) Pentazocine (Pentazocine) (Im idapril) (Pentobarbital) (Iofluprédone) (Pentoxifylline) Phenacaine (Phénacaïne) (Isopropamide) Pheniramine (Phéniramine) Ketamine (Kétam ine) Ketanserine (Kétanserine) Ketoprofen (Kétoprofène) Levamisole Elim ination Guidelines T elmisartan (Telm isartan) T epoxalin (Tépoxaline) T estosterone (Testostérone) T etracaine (Tétracaïne) Phenylpropanolamine (Phénylpropanolam ine) (Théophylline) T hiamylal (Thiam ylal) (Pim obendane) (Thiopental) (Prednisolone) T obacco (Tabac) Prednisone (Prednisone) T olazoline (Tolazoline) Primidone (Prim idone) T olfenamic acid (Acide Procaine (Procaïne) tolfénam ique) Prochlorperazine (Trenbolone) Propionylpromazine (Propionylprom azine) (Triam cinolone) Propofol (Propofol) T ricaine (Tricaïne) Pyrilamine (Pyrilam ine) T richlormethiazide Quinine (Quinine) (Trichlorm éthiazide) T rilostane (Trilostane) (Ractopam ine) Ramipril (Ram ipril) (Trim éprazine) Resocortol (Resocortol) (Tripélennam ine) (Robénacoxib) Vedaprofen (Védaprofène) Romifidine (Rom ifidine) Xylazine (Xylazine) Salicylamide (Salicylam ide) Yohimbine (Yohim bine) Scopolamine (Scopolam ine) Zeranol (Zéranol) Secobarbital (Sécobarbital) Zilpaterol Hydrochloride Selegiline (Sélégiline) (Chlorhydrate de zilpatérol) Sputolysin (Sputolysine) Stanozolol (Stanozolol) Strychnine (Strychnine) Q uantitative Limit
Furosemide (Furosémide) 85 ng/mL in blood Salicylic acid (Acide salicylique) 750 µg/mL in urine 6.5 µg/mL in blood Q uantitative Limit
Procaine (Procaïne) 25 ng/mL in blood CPMA Elimination Guidelines EXPLANATORY NOTES
A. SCHEDULE
The folowing substances are prohibited from occurring in official samples: 1. Al substances not approved in Canada for use in veterinary medicine (this includes all human drugs and all foreign- available products), 2. Any substance in the list (this includes some substances approved in Canada for use in veterinary medicine), 3. Any substance that may interfere with the analysis of an official sample for scheduled substances, and 4. Any substance newly approved in Canada for a period of 240 days, and any substance for which the approval has been cancelled. IMPORTANT
Each pharmaceutical product approved for sale in Canada is assigned a "Drug Identification Number" (D.I.N.), which is marked on the product label. Veterinary drugs are marked "(For) Veterinary Use Only" or "(For) Agricultural Use Only" on the product label. EXAMINE ALL PRODUCT LABELS
CAREFULLY!
The guidelines in this booklet may not be consistent with foreign regulations and laboratory methods. Provision has been made for quantitative limits for certain substances. An official sample wil only be caled positive for these substances if the concentration of the substance is greater than the quantitative limit, and any other regulatory conditions are met. For example, see note B (below). CPMA Elim ination Guidelines B. PENICILLIN G PROCAINE
Under certain conditions, quantitative analysis of a blood sample may be used as the basis for classification of a posit ive or negative with respect to procaine resulting from administration of penicillin G procaine products. T hese conditions include: 1. T he last administration of a product containing penicillin G procaine, at a dose up to 6 milion IU, occurs at least 48 hours before the scheduled post time of the race for which the horse is entered. 2. T he last administration of a product containing penicillin G procaine, at a dose up to 9 milion IU, occurs at least 96 hours before the scheduled post time of the race for which the horse is entered. Dosages above 9 million IU may require a longer withdrawal than 96 hours. 3. Approved procedures are established for notifying provincial officials and collection personnel. 4. Approved procedures are established for colecting a blood 5. A statement is made and a blood sample is provided according to the provisions of section 170 of the Pari-Mutuel Betting Supervision Regulations. If all required conditions are met, a positive will not be classified for procaine unless the concentrat ion in the blood sample is greater than 0.025µg/mL or 25ng/mL, as described in paragraph 3 of the Schedule. It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered. Agriculture and Agri-Food Canada is not responsible for results differing in any way from these results. CPMA Elim ination Guidelines
DRUG NAME
DRUG NAME
Aminocaproic acid Hydrochlorothiazide Chlorpheniramine Meclofenamic acid Methylprednisolone Dextromethorphan Dimethylsulfoxide Procaine hydrochloride Penicillin G Procaine CPMA Elim ination Guidelines
DRUG NAME
DRUG NAME
Triamcinolone acetonide T richlormethiazide T iaprofenic acid 110 CPMA Elimination Guidelines CPMA Elim ination Guidelines 112 CPMA Elimination Guidelines

Source: http://www.horse-canada.com/wp-content/uploads/2016/05/elimination-guidelines.pdf